Sector portfolio · VC firm · Mexico

Vertex Ventures' Biotech portfolio

Vertex Ventures has backed 13 Biotech startups in rounds we track, $2.2B between them, shown by the stage each has reached. The best-funded is Elevatebio.

13startups backed
4stages
$2.2Braised between them
Series C and laterbiggest stage

Vertex Ventures's whole portfolioVertex Ventures's profile

Segment by segment

Series C and later

5 startups · $1.2B raised

  1. ElevateBioElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017.United States$551M
  2. Obsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.United States$210M
  3. Boundless BioBoundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.United States$146M
  4. MoximedMoximed Inc.United States$146M
  5. VisterraVisterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.United States$120M

Series B

4 startups · $517M raised

  1. Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
  2. Harbour BioMedHarbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.China$190M
  3. Palleon PharmaceuticalsPalleon Pharmaceuticals is a clinical-stage biotechnology company based in Waltham, Massachusetts.United States$100M
  4. UHUnited HealthBeijing Zhongliankang Biological TechnologyChina$6.7M

Stage not reported

2 startups · $363M raised

  1. EarLensEarlens is a medical technology company transforming the hearing experience with the only direct sound delivery system.United States$248M
  2. NuvairaNuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.United States$115M

Series A

2 startups · $130M raised

  1. EEyebiotechEyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.United States$65M
  2. 2T27-8 TherapeuticsUnited States$65M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Vertex Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Vertex Ventures?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.